26 /100
MEDIUM RISK
Score updated May 30, 2026

BXP — BXP, Inc. Dilution Risk Tracker

Track BXP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BXP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $1000M remaining capacity
🔁 Convertible Conversion 15%
• Convertible debt present: 5.3% potential dilution
🔔 Track BXP — Get forecast alerts →

💹 Market Data

Market Cap$10.70B
Shares Outstanding159.48M
Float147.83M
Cash$512.78M
Debt$16.36B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 6.2% shares (2025Q4 vs prior)
619 institutional holders · 185.54M shares
#1 VANGUARD GROUP INC 24.03M shares
#2 BlackRock, Inc. 18.32M shares
#3 COHEN & STEERS, INC. 15.38M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest11.09M
Days to Cover6.9
% of Float7.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BXP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BXP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BXP
📊 BXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BXP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.